I. Project Location
Shuidu Industrial Park, Danjiangkou Economic Development Zone
II. Project Construction Background and Market Forecast
1. Project background
At present, our city has cultivated a number of bio-pharmaceutical enterprises. There are three manufacturing enterprises engaged in hormone API intermediates, with an annual output of more than 1,000 tons of steroid hormone API intermediates.
2. Market forecast
Steroid hormones have extremely important medicinal values and have clear roles in life maintenance, regulation of sexual function, organism development, immune regulation, skin disease treatment, and fertility control. There are more than 400 kinds of steroid and hormone drugs that have been marketed abroad, but in China, the occupancy rate of the existing varieties is low, and there is still a great distance from the international advanced level. Steroid and hormone drugs still have a lot of room for development. At present, the main gap between the existing pharmaceutical enterprises in our city in terms of R&D level and strength lies in the development of products and market exploitation. The establishment of the project will change the very pattern, focusing on product development and market exploitation to promote R&D, industrialization, and marketing of steroid and hormone drugs.
III. Necessity of Project Construction
At present, China has made the development of new resources for steroid hormone drugs one of the orientations and priorities for the recent technological development of the pharmaceutical industry. For steroid drug R&D, China still lags behind the world's advanced countries, and there are still gaps in the research of many steroid drugs, especially the research of steroid drugs with high technology content, which we urgently need to fill. At present, the city has processed some products in the steroid hormone industry chain, including saponin, diene, 16-17 alpha-Epoxyprogesterone, 17a hydroxyprogesterone, dehydroepiandrosterone, epiandrosterone, and 17-methyltestosterone. The main problems include low production technology, insufficient further processing of products, low added value, and the front position of the industrial chain. These products happen to be very valuable raw materials for steroid hormone drug synthesis. After being further processed into steroid drugs, the added value of these low-value raw materials will be greatly increased, which is very beneficial to the development of the city's pharmaceutical economy.
IV. Construction Scale and Investment Estimate
The total investment of the project is RMB 200 million. A new workshop for cyproterone acetate and intermediates, finasteride and its intermediates, and norgestrel acetate production, a comprehensive office building, and a warehouse should be built. Utilities auxiliary facilities should be set up. After the project is completed and put into operation, it will achieve the annual production capacity of 1,000 kg of cyproterone acetate (CPA), 14,000 kg of cyproterone acetate intermediates, 2,100 kg of finasteride, 6,000 kg of finasteride intermediates, and 4,000 kg of norgestrel acetate.
V. Benefits Analysis
After the project is completed and reaches target output, it is expected to achieve an annual sales revenue of RMB 500 million, a normal annual sales tax of RMB 39.58 million, and a normal annual sales profit of RMB 100 million. The dynamic investment payback period will be 6 years.
Sole proprietorship or joint venture with local enterprises
VII. Employer and Contact Details
Employer: Danjiangkou Investment Promotion Service Center
徐牧 13971933080 0719-5239196
Xu Mu: 13971933080; 0719-5239196